Skip to main content
. 2015 Feb 15;6(1):136–144. doi: 10.4239/wjd.v6.i1.136

Figure 2.

Figure 2

The adjusted mean difference in HbA1c from baseline to 12 wk between placebo and the standard dose of sodium-glucose cotransporter 2 inhibitors. A: 50 mg ipragliflozin in Westerners; B: 50 mg ipragliflozin in Japanese; C: 100 mg canagliflozin in Westerners; D: 10 mg dapagliflozin in Westerners; E: 25 mg empagliflozin in Westerners.